JP2013518116A5 - - Google Patents

Download PDF

Info

Publication number
JP2013518116A5
JP2013518116A5 JP2012551271A JP2012551271A JP2013518116A5 JP 2013518116 A5 JP2013518116 A5 JP 2013518116A5 JP 2012551271 A JP2012551271 A JP 2012551271A JP 2012551271 A JP2012551271 A JP 2012551271A JP 2013518116 A5 JP2013518116 A5 JP 2013518116A5
Authority
JP
Japan
Prior art keywords
protecting group
hydroxyl protecting
alkyl
silyl
oxygen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012551271A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013518116A (ja
JP5800834B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/022611 external-priority patent/WO2011094339A1/en
Publication of JP2013518116A publication Critical patent/JP2013518116A/ja
Publication of JP2013518116A5 publication Critical patent/JP2013518116A5/ja
Application granted granted Critical
Publication of JP5800834B2 publication Critical patent/JP5800834B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012551271A 2010-01-26 2011-01-26 ハリコンドリンb類似体の合成において有用なフロ[3,2−b]ピラン誘導体 Active JP5800834B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29833710P 2010-01-26 2010-01-26
US61/298,337 2010-01-26
PCT/US2011/022611 WO2011094339A1 (en) 2010-01-26 2011-01-26 Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs

Publications (3)

Publication Number Publication Date
JP2013518116A JP2013518116A (ja) 2013-05-20
JP2013518116A5 true JP2013518116A5 (enExample) 2014-03-13
JP5800834B2 JP5800834B2 (ja) 2015-10-28

Family

ID=43726543

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012551271A Active JP5800834B2 (ja) 2010-01-26 2011-01-26 ハリコンドリンb類似体の合成において有用なフロ[3,2−b]ピラン誘導体

Country Status (11)

Country Link
US (6) US8203010B2 (enExample)
EP (1) EP2528914B1 (enExample)
JP (1) JP5800834B2 (enExample)
CN (1) CN102803254B (enExample)
BR (1) BR112012018232B8 (enExample)
CA (1) CA2787919C (enExample)
IL (1) IL220913A (enExample)
MX (1) MX2012008510A (enExample)
RU (1) RU2579511C2 (enExample)
SG (2) SG182612A1 (enExample)
WO (1) WO2011094339A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139960A0 (en) * 1998-06-17 2002-02-10 Eisai Co Ltd Macrocylic analogs and methods of their use and preparation
CN101899026B (zh) 2004-06-03 2016-08-03 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
BRPI0817909B1 (pt) * 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
JP6001857B2 (ja) * 2008-04-04 2016-10-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンb類似体
SI2415470T1 (sl) 2009-03-30 2016-12-30 Eisai R&D Management Co., Ltd. Liposomski sestavek
BR112012018232B8 (pt) 2010-01-26 2023-01-10 Eisai R&D Man Co Ltd Compostos derivados de furo [3,2-b] pirano úteis na síntese de análogos de halicondrina b e métodos de sintetização de er-80402 e de eribulina
GB2526955B (en) 2011-09-18 2016-06-15 Touchtunes Music Corp Digital jukebox device with karaoke and/or photo booth features, and associated methods
WO2014087230A1 (en) 2012-12-04 2014-06-12 Eisai R&D Management Co., Ltd. Use of eribulin in the treatment of breast cancer
ES2705698T3 (es) 2013-06-26 2019-03-26 Eisai R&D Man Co Ltd Terapia de combinación para el tratamiento del cáncer que comprende eribulina y lenvatinib
AU2014286880B2 (en) 2013-07-03 2017-12-14 Sandoz Ag Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing -SO2-(p-TOLYL) groups
CN103483352A (zh) * 2013-10-18 2014-01-01 李友香 抗肿瘤的药用原料药
HUE049387T2 (hu) * 2013-11-04 2020-09-28 Eisai R&D Man Co Ltd A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek
SG10201805024YA (en) 2013-12-06 2018-07-30 Eisai R&D Man Co Ltd Methods useful in the synthesis of halichondrin b analogs
KR20170039096A (ko) 2014-05-28 2017-04-10 에자이 알앤드디 매니지먼트 가부시키가이샤 암의 치료에 있어서 에리불린의 용도
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
KR102662228B1 (ko) 2015-03-04 2024-05-02 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
JP6951248B2 (ja) 2015-03-04 2021-10-20 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. がんを治療するための、pd−1アンタゴニスト及びエリブリンの組合せ
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX380284B (es) * 2015-05-07 2025-03-12 Eisai R&D Man Co Ltd Reacciones de macrociclización e intermediarios y otros fragmentos útiles en la síntesis de macrólidos de halicondrina.
US10676481B2 (en) 2016-02-12 2020-06-09 Eisai R&D Management Co., Ltd. Intermediates in the synthesis of eribulin and related methods of synthesis
JOP20170053B1 (ar) 2016-03-02 2021-08-17 Eisai Randd Man Co Ltd مترافقات جسم مضاد وعقار أساسها إيريبولين وطرق استخدامها
EP3449921B1 (en) 2016-04-28 2023-05-31 Eisai R&D Management Co., Ltd. Eribulin for inhibiting tumor growth
SG11201811671XA (en) 2016-06-30 2019-01-30 Eisai R&D Man Co Ltd Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
JP2019530706A (ja) 2016-10-14 2019-10-24 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 尿路上皮がんを治療するための、pd−1アンタゴニスト及びエリブリンの組合せ
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
CN108658956B (zh) * 2017-03-28 2021-02-02 上海时莱生物技术有限公司 艾日布林中间体及其制备方法
JP7168580B2 (ja) 2017-04-05 2022-11-09 プレジデント アンド フェローズ オブ ハーバード カレッジ 大環状化合物およびその使用
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
CN108948064B (zh) * 2017-05-17 2021-02-02 上海时莱生物技术有限公司 一种艾日布林中间体及其制备方法
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
IL295588B2 (en) 2017-07-06 2024-03-01 Harvard College Synthesis of halichondrins
US20190046513A1 (en) 2017-08-10 2019-02-14 Huya Bioscience International, Llc Combination therapies of hdac inhibitors and tubulin inhibitors
ES2974243T3 (es) 2017-11-15 2024-06-26 Harvard College Compuestos macrocíclicos y usos de los mismos
WO2019097073A1 (en) 2017-11-20 2019-05-23 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of neoplastic diseases
KR20250057138A (ko) 2018-01-03 2025-04-28 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤리드 및 그의 유사체의 합성에 유용한 프린스 반응 및 화합물
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
US12036204B2 (en) 2019-07-26 2024-07-16 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU652180A1 (ru) * 1975-12-16 1979-03-15 Краснодарский политехнический институт 1(Фурил-2,)-2-(2-,, формилфурил-5,, ) этилен или его метильное производное как промежуточный продукт дл синтеза фуран-2,5-дикарбоновой кислоты и способ его получени
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
US5338865A (en) * 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
TW255880B (enExample) 1992-09-09 1995-09-01 Hoechst Ag
JP2001500498A (ja) 1996-09-06 2001-01-16 イーライ・リリー・アンド・カンパニー 触媒選択的スルホニル化法
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
IL139960A0 (en) 1998-06-17 2002-02-10 Eisai Co Ltd Macrocylic analogs and methods of their use and preparation
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
CN101899026B (zh) 2004-06-03 2016-08-03 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
CN109180615A (zh) * 2004-06-03 2019-01-11 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
US20060045846A1 (en) 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
WO2006076100A2 (en) 2004-12-09 2006-07-20 Eisai Co. Ltd. Tubulin isotype screening in cancer therapy using halichondrin b analogs
WO2008010776A1 (en) 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
BRPI0817909B1 (pt) 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
JP5134686B2 (ja) 2007-11-16 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンbアナログ合成のための新規な中間体及び前記中間体に用いるための新規な脱スルホニル化反応
JP6001857B2 (ja) 2008-04-04 2016-10-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンb類似体
BR112012018232B8 (pt) 2010-01-26 2023-01-10 Eisai R&D Man Co Ltd Compostos derivados de furo [3,2-b] pirano úteis na síntese de análogos de halicondrina b e métodos de sintetização de er-80402 e de eribulina
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
EP2785687B1 (en) 2011-11-30 2019-02-20 Sandoz AG Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
CN104334562A (zh) 2012-03-30 2015-02-04 阿方拉研究股份有限公司 用于制备软海绵素b的大环c1-酮类似物的合成方法及其中有用的中间体
AU2014286880B2 (en) 2013-07-03 2017-12-14 Sandoz Ag Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing -SO2-(p-TOLYL) groups
HUE049387T2 (hu) 2013-11-04 2020-09-28 Eisai R&D Man Co Ltd A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek
SG10201805024YA (en) 2013-12-06 2018-07-30 Eisai R&D Man Co Ltd Methods useful in the synthesis of halichondrin b analogs
MX380284B (es) 2015-05-07 2025-03-12 Eisai R&D Man Co Ltd Reacciones de macrociclización e intermediarios y otros fragmentos útiles en la síntesis de macrólidos de halicondrina.
US10676481B2 (en) 2016-02-12 2020-06-09 Eisai R&D Management Co., Ltd. Intermediates in the synthesis of eribulin and related methods of synthesis
SG11201811671XA (en) 2016-06-30 2019-01-30 Eisai R&D Man Co Ltd Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof

Similar Documents

Publication Publication Date Title
JP2013518116A5 (enExample)
RU2012136468A (ru) Производные фуро[3,2,-в]пирана, применимые в синтезе аналогов
JP2012503621A5 (enExample)
JP2007511546A5 (enExample)
JP2010095546A5 (enExample)
JP2010174033A5 (enExample)
JP2014500861A5 (enExample)
RU2012122367A (ru) Способ получения простагландинов и промежуточные соединения для их получения
JP2012508235A5 (enExample)
JP2005525427A5 (enExample)
EA201391158A1 (ru) Диаминиевые соли фенотиазина и их применение
JP2018529687A5 (enExample)
JPWO2020123827A5 (enExample)
JP2012510502A5 (enExample)
JP2010537034A5 (enExample)
JP2011520815A5 (enExample)
JP2012523410A5 (enExample)
JP2013010096A5 (enExample)
JP2016513122A5 (enExample)
JP2017051113A5 (enExample)
JP2009543795A5 (enExample)
RU2012144438A (ru) Производные 1-(2-фторбифенил-4-ил)-алкилкарбоновой кислоты для лечения транстиретинового амилоидоза
JP2017531013A5 (enExample)
JP2013513607A5 (enExample)
JP2008543874A5 (enExample)